GlaxoSmithKline veteran Richard Saynor is coming home to Sandoz after being named the new chief executive officer of the Novartis subsidiary.
In the past 15 months, agencies of all sizes featured in this annual report were active in finding and hiring new talent.
Privately held Talaris Therapeutics secured $100 million in a Series A financing round as the company undergoes a rebranding with a new leadership team.
CMI/Compas, media buying and planning for the nation’s top healthcare companies and part of WPP, announced the promotion of James Woodland to Chief Strategy and Financial Officer.
One is going, one is staying – and getting a promotion.
The loss of patent protection on two drugs is forcing Gilead Sciences to terminate about 20 percent of the company’s sales team, according to reports.
CMI/Compas, media planning and buying for the nation’s top healthcare companies and part of WPP, announced the promotion of John Donovan to President of Compas.
FCB Health Network president and CEO Dana Maiman announced that Kathleen Nanda has been promoted to executive creative director of FCB Health New York.
Ogilvy Health – part of The Ogilvy Group – announced Dan Chichester re-joined the network following a five-year hiatus, returning in the newly created position of Chief Experience Officer (CXO).
CMI/Compas, media buying and planning for the nation’s top healthcare companies and part of WPP (NYSE:WPP), announces the promotion of Dr. Susan Dorfman to President, CMI. Dorfman was most recently Chief Commercial Officer for CMI/Compas. As President, she is responsible for the growth and future direction of CMI Media, with a strategic focus on integrated […]